Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA minor site version update from v3.6.5 to v3.6.6 is reflected on the page. This update does not change the study details or user-facing content.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page footer now displays Revision: v3.6.5, replacing the previous version, indicating a platform update. The study information shown remains the same.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.6.4 has been added, replacing v3.6.3 to indicate a behind-the-scenes website update. No study content or user-facing data changes are indicated.SummaryDifference0.1%

- Check69 days agoChange DetectedThe study page revision label updated from v3.6.2 to v3.6.3, reflecting a minor update to the record without changing substantive content.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag in the footer was updated from v3.6.0 to v3.6.2, signaling a small update to the page's underlying version.SummaryDifference0.1%

- Check90 days agoChange DetectedThe study page now shows 'No longer looking for participants' and adds new sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', while removing the old 'Intervention / Treatment' heading and the prior 'Revision: v3.5.5' note.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.